IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Gross margin 2023–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) gross margin by fiscal year — reported gross profit divided by reported revenue.
34.3%FY2025 · since FY2023: 13.1% → 34.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 34.3% | -8.9 pp |
| FY2024 | 43.2% | +30.0 pp |
| FY2023 | 13.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice